February 18, 2021 02:00 AM EST
Financing

Ad­vent Life Sci­ences launch­es two funds to­tal­ing $215M, and teams with Har­ring­ton Dis­cov­ery In­sti­tute to trans­late re­search

Max Gelman

Senior Editor

Long­time ear­ly-stage in­vestor Ad­vent Life Sci­ences has com­plet­ed two new funds, and they’re ready to spend the cash.

Ad­vent raised a com­bined $215 mil­lion be­tween …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Viking CEO on ‘shock­ing’ mar­ket re­ac­tion to oral obe­si­ty da­ta, prepar­ing for Phase 3

Beam dis­clos­es first clin­i­cal da­ta on base-edit­ed sick­le cell ther­a­py, one pa­tient death

Ver­tex makes mon­ey from sick­le cell ther­a­py Cas­gevy

Sanofi re­veals pos­i­tive da­ta for BTK in­hibitor from $3.7B Prin­cip­ia takeover

Sana nar­rows fo­cus again to ze­ro in on di­a­betes and au­toim­mune dis­ease

sponsored

Gene ther­a­pies don’t have to cost $4 mil­lion: New pro­duc­tion plat­forms re­duce de­vel­op­ment costs and risks

A service from the Financial Times